AAAAAA

   
Results: 1-11 |
Results: 11
ALENDRONATE INCREASES BONE MASS IN PATIENTS RECEIVING GLUCOCORTICOID THERAPY FOR PULMONARY-DISEASES
Authors: MCCLUNG M YANOVER M MENKES CJ RODRIGUEZPORTALES JA CZACHUR M CAROFANO W MALICE MP DAIFOTIS AG
Citation: M. Mcclung et al., ALENDRONATE INCREASES BONE MASS IN PATIENTS RECEIVING GLUCOCORTICOID THERAPY FOR PULMONARY-DISEASES, Journal of allergy and clinical immunology, 101(1), 1998, pp. 16-16
ALENDRONATE FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
Authors: SAAG KG EMKEY R SCHNITZER TJ BROWN JP HAWKINS F GOEMAERE S THAMSBORG G LIBERMAN UA DELMAS PD MALICE MP CZACHUR M DAIFOTIS AG
Citation: Kg. Saag et al., ALENDRONATE FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS, The New England journal of medicine, 339(5), 1998, pp. 292-299
CONTINUED IMPROVEMENT OVER 2 YEARS IN PRESSURE-FLOW PARAMETERS IN MENON FINASTERIDE
Authors: BARRETT D TAMMELA T ABRAMS P HEDLUND H ROLLEMA H NORDLING J ANDERSEN J HALD T MATOSFERRIERA A BRUSKEWITZ R MILLER P KIRBY R MALICE MP BACH MA JACOBSEN CA SCHAFER W
Citation: D. Barrett et al., CONTINUED IMPROVEMENT OVER 2 YEARS IN PRESSURE-FLOW PARAMETERS IN MENON FINASTERIDE, The Journal of urology, 159(5), 1998, pp. 1278-1278
CONSISTENCY OF EFFECT OF ALENDRONATE IN GLUCOCORTICOID-INDUCED AND POSTMENOPAUSAL OSTEOPOROSIS
Authors: ERNKEY R SAAG K BROWN J CORREAROTTER R MALICE MP CAROFANO W DALFOTIS A
Citation: R. Ernkey et al., CONSISTENCY OF EFFECT OF ALENDRONATE IN GLUCOCORTICOID-INDUCED AND POSTMENOPAUSAL OSTEOPOROSIS, Arthritis and rheumatism, 41(9), 1998, pp. 72-72
ALENDRONATE INCREASES BONE-MINERAL DENSITY IN MEN RECEIVING GLUCOCORTICOIDS
Authors: GRUBER B GOEMAERE S LIBERMAN UA ADACHI J DAIFOTIS AG MALICE MP CZACHUR M
Citation: B. Gruber et al., ALENDRONATE INCREASES BONE-MINERAL DENSITY IN MEN RECEIVING GLUCOCORTICOIDS, Arthritis and rheumatism, 41(9), 1998, pp. 629-629
DO DISEASE AND CONCOMITANT MEDICATIONS INFLUENCE THE EFFECT OF ALENDRONATE ON SPINE BMD IN PATIENTS RECEIVING GLUCOCORTICOIDS
Authors: HAWKINS F EPSTEIN S HAMDY N TESSER J MALICE MP DAIFOTIS AG ESPINOSA D
Citation: F. Hawkins et al., DO DISEASE AND CONCOMITANT MEDICATIONS INFLUENCE THE EFFECT OF ALENDRONATE ON SPINE BMD IN PATIENTS RECEIVING GLUCOCORTICOIDS, Arthritis and rheumatism, 41(9), 1998, pp. 1616-1616
BIOLOGIC VARIABILITY OF PROSTATE-SPECIFIC ANTIGEN AND ITS USEFULNESS AS A MARKER FOR PROSTATE-CANCER - EFFECTS OF FINASTERIDE
Authors: OESTERLING JE ROY J AGHA A SHOWN T KRARUP T JOHANSEN T LAGERKVIST M GORMLEY G BACH M WALDSTREICHER J LIEBER M HAMPSEY J POULSEN J EKMAN P JOHANSEN TEB HUDSON PB TAMMELA T MUSTONEN S VARENHORST E HJERTBERG H IMPERATOMCGINLEY J GINGELL JC THOMAS SA WOLF H LANGE P ELLIS W BAERT LVM BARTSCH G BEISLAND HO SUGIMOTO D EINARSON GV NURMI M IVERSEN P TOCKER P MALICE MP
Citation: Je. Oesterling et al., BIOLOGIC VARIABILITY OF PROSTATE-SPECIFIC ANTIGEN AND ITS USEFULNESS AS A MARKER FOR PROSTATE-CANCER - EFFECTS OF FINASTERIDE, Urology, 50(1), 1997, pp. 13-18
ALENDRONATE INCREASES BONE-MINERAL DENSITY IN PATIENTS ON GLUCOCORTICOID THERAPY - RESULTS OF THE MULTINATIONAL STUDY
Authors: POUBELLE PE ADACHI J HAWKINS F GOEMAERE S THAMSBORG G DELMAS P MENTEN J MALICE MP CZACHUR M DAIFOTIS A
Citation: Pe. Poubelle et al., ALENDRONATE INCREASES BONE-MINERAL DENSITY IN PATIENTS ON GLUCOCORTICOID THERAPY - RESULTS OF THE MULTINATIONAL STUDY, Arthritis and rheumatism, 40(9), 1997, pp. 1774-1774
NONVERTEBRAL FRACTURE AND BONE-DENSITY IN GLUCOCORTICOID-TREATED PATIENTS
Authors: GOEMAERE S ADACHI J HAWKINS F LANE N POUBELLE P SAAG K SCHNITZER T MALICE MP FREEDHOLM D CZACHUR M DAIFOTIS A
Citation: S. Goemaere et al., NONVERTEBRAL FRACTURE AND BONE-DENSITY IN GLUCOCORTICOID-TREATED PATIENTS, Arthritis and rheumatism, 39(9), 1996, pp. 371-371
CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY
Authors: ANDERSEN JT EKMAN P WOLF H BEISLAND HO JOHANSSON JE KONTTURI M LEHTONEN T TVETER K BODKER A VEDEL O NORDLING J POULSEN AL SCHOU J HVIDT V HANSEN JB MEYHOFF HH ELDRUP J HARTWELL D COLSTRUP H LYNGDORF P NIELSEN AH LARSEN E WALTER S LARSEN EH THYBO E MOMMSEN S BROK KE PALM L GENSTER H ANDERSEN M KAUPPINEN P RAUVALA M HAKKINEN J TAMMELA T TAINIO H HYNNINEN O TIITINEN J LEHTORANTA K ALAOPAS M PERTTILA I PETAS A RINTALA E SALMINEN R JUUSELA H HANSSON E VONWENDT R TUHKANEN K TALJA M NURMI M PUNTALA P PERMI J PUOLAKKA VM VIITANEN J GISLASON T EINARSSON GV ERI LM KARLSEN S HOLME P SIVERTSEN SM STEINSVIK E SERVOLL E URNES T MALME PA JOHANSEN TEB OMLAND H NAGELHUS J KLOSTER SE SKJEGGESTAD O VADA K MORTENSEN R NYBERG G PETTERSSON G WEDMAN L BRATELL S FOLMERZ P ZACKRISSON B DAHLGREN K TILLEGARD A AUS G BERGDAHL S HUGOSSON J HOLMQUIST B EK A RADEMARK C KRISTIANSEN P HERMANSSON CG PEDERSEN K OSCARSSON C KIHL B OLSSON JO NELVIN L LEISSNER KH LUNDSTAM S HJERTBERG H VARENHORST E ANDERSSON SO WINDAHL T SWARTZ R AHLBERG B GEDDA S ANDERSTROM C EDDELAND S HANSSON R STROGERG P ADOLFSSON J BAUER P KLEIST H STORM B RANCH T STRAVSNES H BREKKAN E EKLUND T KARLBERG L MALICE MP BRONEE V WENNERLUND P ERIKSSON LO AASERUD E LEHMUSSAARI J SUOMIN R GABRIEL MA
Citation: Jt. Andersen et al., CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY, Urology, 46(5), 1995, pp. 631-637
COMPARISON OF FINASTERIDE (PROSCAR(R)) AND SERENOA REPENS (PERMIXON(R)) IN THE INHIBITION OF 5-ALPHA REDUCTASE IN HEALTHY MALE-VOLUNTEERS
Authors: STRAUCH G PERLES P VERGULT G GABRIEL M GIBELIN B CUMMINGS S MALBECQ W MALICE MP
Citation: G. Strauch et al., COMPARISON OF FINASTERIDE (PROSCAR(R)) AND SERENOA REPENS (PERMIXON(R)) IN THE INHIBITION OF 5-ALPHA REDUCTASE IN HEALTHY MALE-VOLUNTEERS, European urology, 26(3), 1994, pp. 247-252
Risultati: 1-11 |